Etiology, Treatment and Prognosis of Acute Pericarditis
DOI:
https://doi.org/10.24950/O/185/19/1/2020Keywords:
Acute Disease, Pericarditis/diagnosis, Pericarditis/etiology, Pericarditis/therapy, PrognosisAbstract
Introduction: Acute pericarditis is a common inflammatory condition of the pericardium usually assumed to be viral or idiopathic. Despite recent treatment improvements, information is scarce regarding etiology and prognosis. Our aim was to determine the incidence of pericarditis with a known etiology and assess clinical prognostic predictors.
Material and Methods: A clinical retrospective analysis of hospitalized patients with acute pericarditis was conducted from 2012 to 2016. Population was characterized according to etiology, clinical presentation, treatment and prognosis. Outcomes of interest, evaluated at one year after hospital discharge, were pericarditis recurrence, hospitalization, constric- tion and overall mortality.
Results: A total of 94 patients were enrolled, median age 46 years (inter-quartile range 32-61), 65% were male. Idio- pathic etiology was responsible for 68% of cases. A specific etiology was found in the remaining 32% of patients, being the most frequent autoimmune disease (12%) and malignancy (5%). Idiopathic pericarditis was associated with myopericarditis (p = 0.049) and a known etiology with pericardial effusion (p = 0.001) and cardiac tamponade (p = 0.027). Recurrence of pericarditis was found in 13% of patients. Corticosteroid treatment in patients with an identified etiology was not associated with an increase in recurrence (p = 0.220). Overall 1-year mortality was 9%. A defined etiology was the only independent predictor of mortality at multivariate analysis (OR 40.3; 95% CI 1.9 – 137.2; p = 0.016).
Conclusion: Up to one third of hospitalized patients with acute pericarditis have an identified cause of pericarditis and these patients are at increased risk of mortality.
Downloads
References
Imazio M, Cecchi E, Demichelis B, Chinaglia A, Ierna S, Demarie D, et al. Myopericarditis versus viral or idiopathic acute pericarditis. Heart. 2008, 94:498–501.
Sheith S, Wang DD, Kasapis C. Current and emerging strategies for the treatment of acute pericarditis: a systematic review. J Inflamm Res. 2010; 3:135 – 42. doi: 10.2147/JIR.S10268.
Imazio M. Contemporary management of acute pericarditis. Curr Opin Cardiol. 2012, 27:308-17. doi: 10.1097/HCO.0b013e3283524fbe.
Permanyer-Miralda G, Sagrista-Sauleda J, Soler-Soler J. Primary acute pericardial disease: a prospective series of 231 consecutive patients. Am J Cardiol. 1985; 56:623–30.
Ilan Y, Oren R, Ben-Chetrit E. Acute pericarditis: etiology, treatment and prognosis. A study of 115 patients. Jpn Heart J. 1991;32:315-21.
Zayas R, Anguita M, Torres F, Giménez D, Bergillos F, Ruiz M, et al. Incidence of specific etiology and role of methods for specific etiologic diagnosis of primary acute pericarditis. Am J Cardiol. 1995; 75:378–82.
Imazio M, Brucato A, DeRosa FG, Lestuzzi C, Bombana E, Scipione F, et al. Aetiological diagnosis in acute and recurrent pericarditis: when and how. J Cardiovasc Med. 2009, 10:217–30. doi: 10.2459/JCM.0b013e328322f9b1.
Mayosi BM. Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa. Heart. 2007; 93:1176 – 83. doi: 10.1136/hrt.2007.127746.
Imazio M, Bobbio M, Cecchi E, Demarie D, Demichelis B, Pomari F, et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation. 2005; 112:2012–6.
Imazio M, Bobbio M, Cecchi E, Demarie D, Pomari F, Moratti M, et al. Colchicine as first choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med. 2005; 165:1987–91.
Imazio M, Brucato A, Cemin R, Ferrua S, Maggiolini S, Beqaraj F, et al. A randomized controlled trial of colchicine for acute pericarditis. N Engl J Med 2013;369:1522-8. doi: 10.1056/NEJMoa1208536
Imazio M, Spodik D, Bracato A, Trinchero R, Adler Y. Controversial issues in the management of pericardial diseases. Circulation. 2010; 121:916-28. doi: 10.1161/CIRCULATIONAHA.108.844753.
Imazio M, Cecchi E, Demichelis B, Ierna S, Demarie D, Ghisio A, et al. Indi- cators of poor prognosis of acute pericarditis. Circulation. 2007; 115:2739-44
Caetano J, Fernandes das Neves M, Oliveira S, Delgado Alves J. Xanthogranulomatous pyelonephritis presenting as palmoplantar keratoderma BMJ Case Rep. 2014; 2014 doi:10.1136/bcr-2014-208511.
Caforio AL, Brucato A, Doria A, Brambilla G, Angelini A, Ghirardello A, et al. Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart. 2010;96:779-84. doi: 10.1136/hrt.2009.187138.
Imazio M, Demichelis B, Parrini I, Giuggia M, Cecchi E, Gaschino G, et al. Day-hospital treatment of acute pericarditis. J Am Coll Cardiol. 2004 ;43:1042–6.
Søgaard KK, Farkas DK , Ehrenstein V, Bhaskaran K, Bøtker HE, Sørensen HT. Pericarditis as a marker of occult cancer and a prognostic factor for cancer mortality. Circulation. 2017; 136:996–1006. doi: 10.1161/CIRCULATIONAHA.116.024041.
Pankuweit S, Ristic AD, Seferovic PM, Maisch B. Bacterial pericarditis: diag- nosis and management. Am J Cardiovasc Drugs. 2005; 5:103-12.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna